Simcere's Montmorillonite (Biqi) passed Quality Consistency Evaluation for Generic Drugs

According to the database of the State Food and Drug Administration, "Biqi®-Montmorillonite Powder"  manufactured by Simcere Pharmaceutical (Hainan) Co., Ltd. is among the first batch of montmorillonite powder products to have passed the SFDA's Quality Consistency Evaluation for Generic Drugs.

Biqi® is a Class I OTC drug  for diarrhea. Biqi® APIs and preparations have passed the EU GMP certification, and are also included in the national health insurance catalogue since 2004.

© Copyright 2016 All Rights Reserved. 澳门葡京网站平台